Status:
COMPLETED
Solute Removal With High Volume Hemodiafiltration Versus Long High Flux Hemodialysis
Lead Sponsor:
University Hospital, Ghent
Conditions:
End-stage Renal Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective cross-over study including 10 stable hemodialysis patients with chronic kidney disease stage 5. The cross-over study lasts 2 weeks with the study dialysis sessions at midweek. D...
Eligibility Criteria
Inclusion
- Chronic kidney disease (CKD) stage 5 with hemodialysis or hemodiafiltration treatment for more than three months.
- No vascular access related problems (Arteriovenous (A/V) fistula, graft or bi-flow catheter)
- Double needle/lumen vascular access
- No ongoing infection
- Singed informed consent form
Exclusion
- Inclusion criteria not met
- Known HIV or active hepatitis B or C infection (Positive Polymerisation Chain Reaction (PCR))
- Pregnancy
- Unstable clinical condition (e.g. cardiac or vascular instability)
- Known coagulation problems
- Patients participating in another study interfering with the planned study.
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 29 2014
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT01445366
Start Date
April 1 2012
End Date
September 29 2014
Last Update
December 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium, 9000